Latvia offers specialized international prostate cancer care through centers focusing on advanced radiation and immunotherapy. Leading facilities include SRC Sigulda for CyberKnife technology and Pallas Clinic for integrative oncology. These centers provide targeted, non-invasive alternatives to traditional surgery for global patients.
- Stereotactic radiosurgery: SRC Sigulda uses CyberKnife for robotic, non-invasive tumor destruction.
- Treatment timeframe: CyberKnife protocols typically require 5 sessions instead of several weeks.
- Integrative immunotherapy: Pallas Clinic combines conventional treatments with DCT and CIK therapies.
- Specialized expertise: Dr. Inta Jaunalksne at Pallas Clinic has over 30 years experience.
Bookimed Expert Insight: While state hospitals in Riga handle high volumes of local cases, international patients find better support in private clinics like Pallas Clinic or SRC Sigulda. These facilities are specifically designed for medical travelers. They often maintain higher English-proficiency levels and offer more specialized technologies like CyberKnife that are not always available in general public hospitals.
Patient Consensus: Patients note that while local state hospitals provide competent basic care, they often face significant language barriers and long wait times. Many prefer private centers in Sigulda or Jūrmala for a smoother experience and access to advanced focal therapies.